{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:36:10Z","timestamp":1790368570774,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.kint.2019.08.018","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T12:18:06Z","timestamp":1567513086000},"page":"1389-1399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up"],"prefix":"10.1016","volume":"96","author":[{"given":"Sander F.","family":"Garrelfs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Rumsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessel","family":"Peters-Sengers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Erger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap W.","family":"Groothoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo B.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel J.S.","family":"Oosterveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Salido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham W.","family":"Lipkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally-Anne","family":"Hulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2019.08.018_bib1","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","article-title":"Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria","volume":"26","author":"Hopp","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.08.018_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJMra1301564","article-title":"Primary hyperoxaluria","volume":"369","author":"Cochat","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.08.018_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00240-017-0996-8","article-title":"Primary hyperoxaluria in populations of Pakistan origin: results from a literature review and two major registries","volume":"46","author":"Talati","year":"2018","journal-title":"Urolithiasis"},{"key":"10.1016\/j.kint.2019.08.018_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM196802012780502","article-title":"L-glyceric aciduria. A new genetic variant of primary hyperoxaluria","volume":"278","author":"Williams","year":"1968","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.08.018_bib5","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1042\/bst0160626","article-title":"Hepatic D-glycerate dehydrogenase and glyoxylate reductase deficiency in primary hyperoxaluria type 2","volume":"16","author":"Mistry","year":"1988","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.kint.2019.08.018_bib6","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/8.11.2063","article-title":"The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II","volume":"8","author":"Cramer","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.kint.2019.08.018_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/000456329803500114","article-title":"Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase\/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2","volume":"35","author":"Giafi","year":"1998","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.kint.2019.08.018_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/BJ20051397","article-title":"Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese hamster ovary cells","volume":"394","author":"Behnam","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.kint.2019.08.018_bib9","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/ndt\/16.8.1697","article-title":"Primary hyperoxaluria type 2 without L-glycericaciduria: is the disease under-diagnosed?","volume":"16","author":"Rumsby","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.08.018_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1523-1755.2001.00462.x","article-title":"Phenotypic expression of primary hyperoxaluria: comparative features of types I and II","volume":"59","author":"Milliner","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.08.018_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0272-6386(12)80981-4","article-title":"Long-term prognosis in primary hyperoxaluria type II (L-glyceric aciduria)","volume":"23","author":"Chlebeck","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2019.08.018_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/0004563214529937","article-title":"The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary hyperoxaluria: a review of data from a referral centre","volume":"52","author":"Clifford-Mobley","year":"2015","journal-title":"Ann Clin Biochem"},{"issue":"suppl 1","key":"10.1016\/j.kint.2019.08.018_bib13","first-page":"56","article-title":"Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2","volume":"11","author":"Milliner","year":"1998","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.kint.2019.08.018_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s004310050649","article-title":"Primary hyperoxaluria type 2","volume":"156","author":"Kemper","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.kint.2019.08.018_bib15","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJM199406093302318","article-title":"End-stage renal failure in primary hyperoxaluria type 2","volume":"330","author":"Marangella","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.08.018_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00467-002-0858-6","article-title":"Primary hyperoxaluria type 2 in children","volume":"17","author":"Johnson","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2019.08.018_bib17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJM198309293091317","article-title":"Fifteen-year follow-up of hyperoxaluria type II","volume":"309","author":"Hicks","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2019.08.018_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00392-006-0362-2","article-title":"Restrictive cardiomyopathy in a patient with primary hyperoxaluria type II","volume":"95","author":"Schulze","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.kint.2019.08.018_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S2213-8587(15)00372-1","article-title":"Calcified nodules on fingers in primary hyperoxaluria type 2","volume":"4","author":"Yamanouchi","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2019.08.018_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/ajt.14418","article-title":"Combined liver-kidney transplantation for primary hyperoxaluria type 2: a case report","volume":"18","author":"Dhondup","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2019.08.018_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ajt.14550","article-title":"Recurrence of oxalate nephropathy after isolated kidney transplantation for primary hyperoxaluria type 2","volume":"18","author":"Del Bello","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2019.08.018_bib22","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1111\/j.1600-6143.2010.03271.x","article-title":"Transplantation outcomes in primary hyperoxaluria","volume":"10","author":"Bergstralh","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2019.08.018_bib23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1053\/ajkd.2001.29229","article-title":"Novel mutation in the GRHPR gene in a Chinese patient with primary hyperoxaluria type 2 requiring renal transplantation from a living related donor","volume":"38","author":"Lam","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"suppl 8","key":"10.1016\/j.kint.2019.08.018_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/10.supp8.58","article-title":"Primary hyperoxaluria type 2","volume":"10","author":"Mansell","year":"1995","journal-title":"Nephrol Dial Transplant"},{"issue":"pt 4","key":"10.1016\/j.kint.2019.08.018_bib25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0004563215606158","article-title":"Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria","volume":"53","author":"Clifford-Mobley","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.kint.2019.08.018_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/humu.9200","article-title":"Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2","volume":"22","author":"Cregeen","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.kint.2019.08.018_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s004390000351","article-title":"Identification of missense, nonsense and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2)","volume":"107","author":"Webster","year":"2000","journal-title":"Hum Genet"},{"key":"10.1016\/j.kint.2019.08.018_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mgg3.118","article-title":"Performance evaluation of Sanger sequencing for the diagnosis of primary hyperoxaluria and comparison with targeted next generation sequencing","volume":"3","author":"Williams","year":"2015","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.kint.2019.08.018_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.kint.2019.08.018_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00240-016-0860-2","article-title":"Urine oxalate biological variation in patients with primary hyperoxaluria","volume":"44","author":"Clifford-Mobley","year":"2016","journal-title":"Urolithiasis"},{"key":"10.1016\/j.kint.2019.08.018_bib31","unstructured":"Rumsby G, Hulton SA. Primary hyperoxaluria type 2. In: Adam MP, Ardinger HH, Pagon RA, et\u00a0al., editors. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2018. Published December 21,\u00a02017."},{"key":"10.1016\/j.kint.2019.08.018_bib32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/0004563218811365","article-title":"Rapid liquid chromatography tandem mass-spectrometry screening method for urinary metabolites of primary hyperoxaluria","volume":"56","author":"Woodward","year":"2019","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.kint.2019.08.018_bib33","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ki.2014.222","article-title":"Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type","volume":"86","author":"Mandrile","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.08.018_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2215\/CJN.02810315","article-title":"Predictors of incident ESRD among patients with primary hyperoxaluria presenting prior to kidney failure","volume":"11","author":"Zhao","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.08.018_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ki.2014.298","article-title":"Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria","volume":"87","author":"Tang","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2019.08.018_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000086361","article-title":"Primary hyperoxaluria type 1 in Japan","volume":"25","author":"Takayama","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2019.08.018_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ndt\/18.2.273","article-title":"Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome","volume":"18","author":"van Woerden","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2019.08.018_bib38","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.ymthe.2018.05.016","article-title":"Specific inhibition of hepatic lactate dehydrogenase reduces oxalate production in mouse models of primary hyperoxaluria","volume":"26","author":"Lai","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.kint.2019.08.018_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2019.08.018_bib40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kint.2019.08.018_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819308452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253819308452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:54:08Z","timestamp":1758761648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253819308452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0085253819308452"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2019.08.018","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2019.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}